前海健康控股有限公司（00911）于2026年3月3日发布截至2026年2月28日的股份变动月报表。公告显示，公司在报告期内无新增股份发行、购回或注销行为，股本结构整体保持不变。
根据公告，公司法定股本注册上限为500,000,000股，面值每股0.4港元，总额为200,000,000港元。本月末已发行普通股数量为169,445,000股，库藏股数量为0股，已发行股份总数维持169,445,000股。
公告同时确认，公司继续符合香港联合交易所有限公司的有关公众持股量规定，且未发生任何股份期权、购回或其他激励计划的变动。公司声明已遵守香港联交所《上市规则》及相关法律要求，所有发行及转让行为均获董事会批准。
本次月报由公司秘书叶德容签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.